Jnana Therapeutics operates a drug discovery platform focused on solute carrier. The Company is focused on immunometabolism, lysosomal function, and mucosal defense, disease pathways where SLC transporters provides target for immuno-oncology, inflammatory disorders, and neurological diseases.